Registration Links (4 Options)
ONC-ORG

Cancer Drug Encyclopedia

Approved oncology medications — what they treat, how they work and key safety information.

DenosumabDenosumab
Targeted Monoclonal AntibodyIntravenous Solution / Subcutaneous Injection

Targeted treatment of solid tumors and hematologic malignancies.

View Drug Details & Inquire→
DexamethasoneDexamethasone
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
Dexrazoxane HydrochlorideDexrazoxane Hydrochloride
Oncology Supportive / Cytoprotective AgentIntravenous Solution

Prevention and management of chemotherapy-related organ toxicities and complications.

View Drug Details & Inquire→
DinutuximabDinutuximab
Targeted Monoclonal AntibodyIntravenous Solution / Subcutaneous Injection

Targeted treatment of solid tumors and hematologic malignancies.

View Drug Details & Inquire→
DocetaxelDocetaxel
Antimicrotubule / Tubulin Inhibitor AgentIntravenous Infusion Solution

Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.

View Drug Details & Inquire→
Dostarlimab-gxlyDostarlimab-gxly
Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)Intravenous Solution / Subcutaneous Injection

Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.

View Drug Details & Inquire→
DoxilDoxorubicin Hydrochloride Liposome
Topoisomerase Inhibitor Chemotherapy AgentIntravenous Solution for Infusion

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

View Drug Details & Inquire→
Doxorubicin HydrochlorideDoxorubicin Hydrochloride
Topoisomerase Inhibitor Chemotherapy AgentIntravenous Solution for Infusion

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

View Drug Details & Inquire→
Doxorubicin Hydrochloride LiposomeDoxorubicin Hydrochloride Liposome
Topoisomerase Inhibitor Chemotherapy AgentIntravenous Solution for Infusion

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

View Drug Details & Inquire→
DurvalumabDurvalumab
Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)Intravenous Solution / Subcutaneous Injection

Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.

View Drug Details & Inquire→
DuvelisibDuvelisib
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→